Nachrichten zur Bristol-Myers Squibb Co. Aktie

Bristol-Myers Squibb meldet Dividende

Der amerikanische Pharmakonzern Bristol-Myers Squibb Co. (ISIN: US1101221083, NYSE: BMY) wird seinen Aktionären am 1. November 2023 eine vierteljährliche Dividende…

Bristol-Myers Squibb Company PFD CONV 2 declares $0.50 dividend

…

Bristol-Myers Squibb Company declares $0.57 dividend

…

Bristol-Myers Squibb Unusual Options Activity For August 21

Bristol Myers (BMY) Announces Positive Updated NSCLC Data

Bristol Myers (BMY) repotrectinib shows durable efficacy benefits in patients with locally advanced or metastatic ROS1-Positive non-small cell lung cancer....…

Could Scientist Find Drug to Treat His Own Disease?

How a researchers 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in…

Bristol-Myers Squibb To Buyback $4 Bln Of Shares Under Accelerated Share Repurchase

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY), a pharma major, said on Thursday that it has inked agreements…

Bristol Myers Sets $4 Billion Accelerated Stock Buyback >BMY

Bristol Myers Sets $4 Billion Accelerated Stock Buyback >BMY...…

Bristol Myers Squibb stock extends bounce after announced $4 billion accelerated buyback agreements

Shares of Bristol Myers Squibb Co. BMY got a 0.9% bump up in premarket trading Thursday, after the biopharmaceutical company…

Insiderhandel: EVP, Chief Research Officer verkauft Aktien von Bristol-Myers Squibb Company im Wert von 44.754$

Plenge, Robert M. - Vorstand - Tag der Transaktion: 2023-08-03...…

Should Dividend Investors Buy Bristol Myers Stock?

The drugmakers near future may be bumpy, but it has a brighter future on the horizon....…

Bristol-Myers Squibb Company PFD CONV 2 goes ex-dividend on Monday

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript

BMY earnings call for the period ending June 30, 2023....…

Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Meta Platforms, Comcast rise; Bristol-Myers, Sunnova fall, Thursday, 7/27/2023

Stocks that are trading heavily or have substantial price changes on Thursday: Meta Platforms, Comcast rise; Bristol-Myers, Sunnova fall...…

Compared to Estimates, Bristol Myers (BMY) Q2 Earnings: A Look at Key Metrics

The headline numbers for Bristol Myers (BMY) give insight into how the company performed in the quarter ended June 2023,…

UPDATE 2-Bristol Myers sales fall, cuts 2023 forecast as drugs face competition

...) By Michael Erman July 27 (Reuters) - Drugmaker Bristol Myers Squibb......…

Bristol Myers sales fall, cuts 2023 forecast as drugs face competition

...By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb......…

Bristol Myers Slashes Forecast on Tumbling Revlimid Sales

Cancer-fighting drugs Revlimid and Pomalyst drive a sales shortfall in the second quarter....…

Bristol-Myers sets below-consensus guidance amid generic competition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers stock takes a hit from earnings miss and lower outlook amid disappointing Revlimid sales

Shares of Bristol Myers Squibb Co. BMY shed 2.2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations…

Bristol-Myers Squibb Q2 adj. EPS $1.75; FactSet consensus $1.98

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb set to continue streak of EPS beats with Q2 results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immatics: 35 Mio. USD-Kapitalbeteiligung von Bristol Myers Squibb

Bildnachweis: Thapana_Studio – stock.adobe.com. Immatics N.V., Spezialist für die Entwicklung und Herstellung von T-Zell-Immuntherapien für die Behandlung von Krebs, gab…

Bristol Myers gets positive opinion from CHMP for Opdivo

The therapy is intended for adults and adolescents aged 12 years and above. This recommendation will be forwarded to the…

Immatics shares jump after investment from Bristol Myers Squibb

Shares of Immatics N.V. IMTX gained more than 8% premarket on Monday after the clinical-stage biopharma company said it had…

Immatics climbs 8% on $35M investment by Bristol Myers Squibb

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb Invests $35 Million in Immatics

Bristol Myers Squibb Invests $35 Million in Immatics...…

Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb

Tuebingen, Germany and Houston, TX, July 24, 2023 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in…

Bristol Myers nabs EU endorsement for Opdivo in melanoma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Gets CHMP Backing for Opdivo in Expanded Melanoma Use >BMY

Bristol Myers Gets CHMP Backing for Opdivo in Expanded Melanoma Use >BMY...…

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

Bristol Myers Squibb (BMY) closed the most recent trading day at $62.06, moving +0.1% from the previous trading session....…

Johnson & Johnson sues Biden administration over Medicare drug price negotiations

Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month....…

HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers (BMY) Reports Positive Data From Urothelial Cancer Study

Bristol Myers (BMY) meets its dual primary endpoint in the late-stage expansion study of Opdivo for the treatment of unresectable…

Tuesday Top Analysts Upgrades and Downgrades: Advance Auto Parts, Blackrock, Bristol-Myers Squibb Company, CAVA Group, Charles Schwab, First Solar, Fox Corporation, Invesco, Northern Trust, Shockwave Medical, Tesla and More

These are the top analyst upgrades, downgrades, and initiations seen before markets opened on Tuesday, July 11, 2023....…

dpa-AFX ProFeed